InvestorsHub Logo
Followers 47
Posts 6378
Boards Moderated 0
Alias Born 06/17/2009

Re: ExtremelyBullishZig post# 96268

Saturday, 03/18/2017 7:19:14 PM

Saturday, March 18, 2017 7:19:14 PM

Post# of 471363
From page of the December 2016 CTAD presentation in San Diego:

9-Months and 12-Months Safety and Exploratory
Efficacy Data of ANAVEX 2-73 in a Phase 2a Study in
Mild-to-Moderate Alzheimer’s Disease Pa-ents

December 10th 2016

Associate Professor Stephen Macfarlane, FRANZCP

Monash University



Dr. MacFarlane is employed and still actively involved in the trial.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News